Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.
Howell I. et al, (2024), J allergy clin immunol
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23.
Cane J. et al, (2024), J infect
Additional effects of oral prednisolone following mepolizumab on the nasal transcriptome
Howell I. et al, (2023), Airway cell biology and immunopathology
Method development for flow-cytometric analysis of primary human airway epithelia infected with non-typeable Haemophilus influenzae
Horton KL. et al, (2022), 03.02 - airway cell biology and immunopathology
Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies.
Jabeen MF. et al, (2022), Microbiol spectr
A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19 – the ATOMIC2 trial
Hinks T. et al, (2021), Thorax, 76
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.
Hinks TSC. et al, (2021), Lancet respir med, 9, 1130 - 1140
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Ramakrishnan S. et al, (2021), Respiratory infections and bronchiectasis
Tight junction molecules are unresponsive in the epithelium of COPD patients during RV infection
Lababidi R. et al, (2021), Mechanisms of lung injury and repair
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Zhuang X. et al, (2021), Iscience, 103144 - 103144
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
Zhuang X. et al, (2021), Biorxiv
Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV1
Cane JL. et al, (2021), International journal of chronic obstructive pulmonary disease, Volume 16, 1437 - 1447
A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 Trial
Hinks TSC. et al, (2021), Ssrn electronic journal
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
Ramakrishnan S. et al, (2021), Lancet respir med
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Ramakrishnan S. et al, (2021)
Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled Trial
Ramakrishnan S. et al, (2021)
Interferon responses are dysfunctional in the epithelium of COPD Patients
Lababidi R. et al, (2020), Airway cell biology and immunopathology
P13 Exhaled nitric oxide and blood eosinophil count in predicting sputum inflammatory type in a heterogeneous airways disease population
Lehtimäki L. et al, (2019), Asthma: endotypes/biomarkers